Action monitoring and depressive symptom reduction in major depressive disorder

被引:80
|
作者
Schrijvers, Didier [1 ]
De Bruijn, Ellen R. A. [1 ,2 ]
Maas, Yvonne J. [2 ]
Vancoillie, Patrick [3 ]
Hulstijn, Wouter [1 ,2 ]
Sabbe, Bernard G. C. [1 ,3 ]
机构
[1] Univ Antwerp, Fac Med, CAPRI, B-2610 Antwerp, Belgium
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HE Nijmegen, Netherlands
[3] Psychiat Hosp Sint Norbertus, B-2570 Duffel, Belgium
关键词
Action monitoring; Error positivity; Error-related negativity; Major depression; Anterior cingulate cortex; ERN; Ne; Pe; EVENT-RELATED POTENTIALS; ERROR-DETECTION; HEALTHY-VOLUNTEERS; ERP COMPONENTS; BRAIN ACTIVITY; NEURAL SYSTEM; RETARDATION; COMPENSATION; FLUOXETINE; ANXIETY;
D O I
10.1016/j.ijpsycho.2008.09.005
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Introduction: Action monitoring has been reported to be disturbed in Major Depressive Disorder (MDD). Well-known markers for this action monitoring process are the error negativity/error-related negativity (Ne/ERN) and error positivity (Pe), both event-related potentials (ERP) generated in the anterior cingulate cortex. This study aims to explore the impact of symptom severity reduction on the Ne/ERN and Pe in MDD. Methods: Behavioural and ERP measurements were obtained in 15 MDD patients during performance on a speeded flankers task during the early stages of a depressive episode and compared with those recorded after 7 weeks of treatment. The same schedule was Used in 15 healthy controls. Results: Whereas overall Ne/ERN and Pe peak amplitudes did not improve front sessions 1 to 2 in the patients, positive correlations emerged between between-session changes in symptom severity and Ne/ERN amplitudes. No such correlations were observed for the Pe. ERP amplitudes in the controls also remained unchanged between both sessions. Significant group differences were observed between MDD patients and controls for the Pe, but not for the Ne/ERN. Conclusions: Whereas a clear association was observed between the level of symptom reduction and the level of improvement in Ne/ERN amplitudes in a MDD sample, no overall Ne/ERN enhancements were observed during symptom remission. Subsequent research is needed to further investigate the possible impact of depressive symptom reduction on the action monitoring in MDD. Several factors that might explain the absence of Ne/ERN group differences between patients and healthy controls in the current sample will also be discussed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 50 条
  • [31] Towards continuous monitoring of depressive mood from locomotor activity in major depressive disorder
    Kim, Jinhyuk
    Nakamura, Toru
    Kikuchi, Hiroe
    Yoshiuchi, Kazuhiro
    Sasaki, Tsukasa
    Yamamoto, Yoshiharu
    Transactions of Japanese Society for Medical and Biological Engineering, 2014, 52
  • [32] Major depressive disorder and depressive symptoms in intermittent explosive disorder
    Medeiros, Gustavo C.
    Seger, Liliana
    Grant, Jon E.
    Tavares, Herman
    PSYCHIATRY RESEARCH, 2018, 262 : 209 - 212
  • [33] Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder
    Mojtabai, Ramin
    Amin-Esmaeili, Masoumeh
    Spivak, Stanislav
    Olfson, Mark
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (04)
  • [34] Covariation of Depressive Mood and Spontaneous Physical Activity in Major Depressive Disorder: Toward Continuous Monitoring of Depressive Mood
    Kim, Jinhyuk
    Nakamura, Toru
    Kikuchi, Hiroe
    Yoshiuchi, Kazuhiro
    Sasaki, Tsukasa
    Yamamoto, Yoshiharu
    IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2015, 19 (04) : 1347 - 1355
  • [35] Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels
    Madhoo, M.
    Roth, R. M.
    Keefe, R. S. E.
    Sambunaris, A.
    Scheckner, B.
    Nielsen, J.
    Adeyi, B.
    Wu, J.
    Lasser, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S233 - S234
  • [36] Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder
    Air, Tracy
    Weightman, Michael J.
    Baune, Bernhard T.
    FRONTIERS IN PSYCHOLOGY, 2015, 6
  • [37] Pupil Dilation during Reward Anticipation Is Correlated to Depressive Symptom Load in Patients with Major Depressive Disorder
    Schneider, Max
    Elbau, Immanuel G.
    Nantawisarakul, Teachawidd
    Pohlchen, Dorothee
    Brueckl, Tanja
    Czisch, Michael
    Saemann, Philipp G.
    Lee, Michael D.
    Binder, Elisabeth B.
    Spoormaker, Victor I.
    BRAIN SCIENCES, 2020, 10 (12) : 1 - 15
  • [38] Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder
    Dunlop, Boadie W.
    Cole, Steven P.
    Nemeroff, Charles B.
    Mayberg, Helen S.
    Craighead, W. Edward
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 229 : 111 - 119
  • [39] Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder
    Papakostas, George I.
    Crawford, Christine M.
    Scalia, Margaret J.
    Fava, Maurizio
    NEUROPSYCHOBIOLOGY, 2007, 56 (2-3) : 132 - 137
  • [40] Accuracy of automated classification of major depressive disorder as a function of symptom severity
    Ramasubbu, Rajamannar
    Brown, Matthew R. G.
    Cortese, Filmeno
    Gaxiola, Ismael
    Goodyear, Bradley
    Greenshaw, Andrew J.
    Dursun, Serdar M.
    Greiner, Russell
    NEUROIMAGE-CLINICAL, 2016, 12 : 320 - 331